The Latest Breaking News from Pfizer

President Trump's praise of Pfizer CEO at Black History Month event sparks mixed audience reactions due to company's Covid-19 vaccine controversy.

Upcoming clinical trial results will give investors a much better look into Pfizer’s operational health.

Pfizer CEO certain that Trump’s administration ‘will be very, very prudent with everything they try to do’

Pfizer tock edged lower Tuesday on a "pretty uneventful quarter" as revenue from its Covid products helped drive a fourth-quarter beat.

The Dow Jones dropped Tuesday as China imposed tariffs on U.S. imports in response to President Trump's tariffs. Palantir surged on earnings.

March S&P 500 E-Mini futures (ESH25) are down -0.21%, and March Nasdaq 100 E-Mini futures (NQH25) are down -0.11% this morning as investors adopted a cautious stance after China retaliated to new U.S. tariffs.

March S&P 500 E-Mini futures (ESH25) are down -0.01%, and March Nasdaq 100 E-Mini futures (NQH25) are up +0.08% this morning as investors awaited the latest reading on U.S. job openings, comments from Federal Reserve officials, and corporate earnings reports from heavyweight names.

Last week was extremely busy on the earnings front, so this week is a little more sedate. That being said, we still have some big names due to report including Amazon, Alphabet, Walt Disney, Palantir Technologies, Advanced Micro Devices, Microstrategy, Uber Technologies and Pfizer.

A guide to the people and activist organizations who paved the way for Donald Trump's attacks on diversity practices in corporate America.